Transcript of OCTANe Q&A with TearClear CEO Kevin Hershfield

Visit TearClear’s website to see the transcript of a conversation between Kevin Hershfield and OCTANe to learn how the company is on a path to solve a critical unmet need in ophthalmology. Click here to view a PDF version.

-Shared by Tyler Stowater, board member of TearClear Corp.